Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts 5 Best-performing Canadian Pharma Stocks of 2025 July 30, 2025 Steve Barton: Gold, Silver, Uranium — Price Targets and Key Levels to Watch July 30, 2025 Maritime Announces Repayment of Senior Secured Notes Due August 14, 2025 July 30, 2025